# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Primary progressive aphasia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 75 results.
Baseline Severity and tDCS in PPA
Status: Recruiting
Last Changed: Jan 25, 2019
First Received: Oct 10, 2016
Disease(s): Primary Progressive Aphasia
Intervention(s): transcranial direct current stimulation
Locations: University of Pennsylvania, Philadelphia, Pennsylvania, United States
rTMS for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Trial
Status: Not yet recruiting
Last Changed: Feb 27, 2018
First Received: Feb 27, 2018
Disease(s): Aphasia, Primary Progressive, Repetitive Transcranical Magnetic Stimulation
Intervention(s): Magstim rTMS
Intranasal Oxytocin for Frontotemporal Dementia
Status: Recruiting
Last Changed: Jan 31, 2019
First Received: Aug 24, 2017
Disease(s): Frontotemporal Dementia
Intervention(s): Syntocinon
Locations: UCLA, Los Angeles, California, United States
University of California, San Francisco, San Francisco, California, United States
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Massachusetts General Hospital, Charlestown, Massachusetts, United States
Columbia University Medical Center, New York, New York, United States
... and 7 other locations.
Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Status: Recruiting
Last Changed: Jun 03, 2019
First Received: Feb 26, 2015
Disease(s): Familial Frontotemporal Dementia
Locations: University of California, San Francisco, Memory and Aging Center, Department of Neurology, San Francisco, California, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Harvard University, Charlestown, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, Saint Louis, Missouri, United States
... and 4 other locations.
Can Magnetic Brain Stimulation Improve Language Function in Primary Progressive Aphasia
Status: Not yet recruiting
Last Changed: Dec 10, 2019
First Received: Dec 10, 2019
Disease(s): Logopenic Progressive Aphasia
Intervention(s): MagStim Rapid2 Transcranial Magnetic Simulation
Intranasal Insulin in Frontotemporal Dementia (FTD)
Status: Recruiting
Last Changed: Oct 04, 2019
First Received: Oct 04, 2019
Disease(s): Frontotemporal Dementia, Behavioral Variant
Intervention(s): Novolin-R insulin
Locations: HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Evaluation of a Transcranial Stimulation With Direct Current on Language Disorders in Semantic Dementia
Status: Not yet recruiting
Last Changed: Mar 29, 2018
First Received: Mar 29, 2018
Disease(s): Semantic Dementia
Intervention(s): Transcranial stimulation
Locations: Département de Neurologie - Centre des maladies neurologiques, cognitives et comportementales, Paris, France
Hôpital de la Pitié-Salpétrière, Paris, France
Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Aug 10, 2016
Disease(s): Frontotemporal Dementia (FTD)
Intervention(s): Lithium Carbonate, Placebo
Locations: Columbia University Medical Center, New York, New York, United States
Induced Pluripotent Stem Cells for Niemann Pick Disease
Status: Recruiting
Last Changed: Apr 25, 2019
First Received: Mar 21, 2019
Disease(s): Niemann-Pick Diseases
Locations: Childrens Hospital and Institute of Child Health, Ferozepur Road, Lahore, Pakistan
Open‐Label Study of Long‐Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann‐Pick Disease Type C
Status: Recruiting
Last Changed: Mar 28, 2019
First Received: Mar 28, 2019
Disease(s): Niemann-Pick Disease, Type C1
Intervention(s): Hydroxypropyl-β-cyclodextrin
Locations: UCSF Benioff Children's Hospital Oakland, Oakland, California, United States